﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropharmacology</JournalTitle>
      <Issn>2345-4202</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The adverse effects of gestational diabetes mellitus on maternal and neonatal kidneys</ArticleTitle>
    <FirstPage>e10632</FirstPage>
    <LastPage>e10632</LastPage>
    <ELocationID EIdType="doi">10.34172/npj.2023.10632</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Afagh</FirstName>
        <LastName>Hassanzadeh Rad</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6980-8866</Identifier>
      </Author>
      <Author>
        <FirstName>Niloufar</FirstName>
        <LastName>Nazeri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8547-8550</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/npj.2023.10632</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>06</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <Abstract>Gestational diabetes mellitus (GDM) is a complication of pregnancy defined as any level of early or first detection of glucose intolerance in pregnancy. It is a prevalent metabolic disorder associated with several maternal and neonatal complications. On the other hand, chronic kidney disease is a leading cause of premature morbidity and mortality worldwide, and diabetic nephropathy accounts for approximately half of all cases of end-stage renal disease. Due to these two conditions’ high prevalence and significance, any possible association would be a public health concern requiring further investigation. To this end, the current study aimed to review the adverse effects of GDM on maternal and neonatal kidneys.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Diabetes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pregnancy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Infant</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>